// App-Quantinova.ai

P6-11-07 : Perioperative administration of desmopressin (dDAVP) in breast cancer patients: A phase II dose-escalation study

Researchers

Presenter

  • Weinberg RS

Principal Investigators

  • Grecco MO

  • Ferro GS

  • Ciccia GN

  • Torbidoni AV

  • Garona J

  • Pifano M

  • Ripoll GV

  • Gomez RE

  • Terrier FJ

  • Sanchez Luceros A

  • Domenichini E

  • Guthmann

  • Di Leo D

  • Spitzer E

  • Alonso DF

  • Seigelshifer D

  • Perroni NV

Medical Centers

  • Elea Laboratories, Buenos Aires, Argentina

  • National University of Quilmes, Buenos Aires, ArgentinaItalian Hospital, La PlataAlexander Fleming Institute, Buenos Aires, Argentina

  • IMEX-CONICET - National Academy of Medicine, Buenos Aires, Argentina

  • Chemo-Romikin, Buenos Aires, Argentina

Locations

  • Argentina

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

  • Cytokeratin 19

Drug/Treatment

  • Desmopressin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved